Dr. Glen Hanson received his D.D.S. from UCLA in 1973 and his Ph.D. in Pharmacology from the University of Utah in 1978 and completed a fellowship in Neuropharmacology in 1980 at the National Institutes of Health (NIH, Bethesda MD). He practiced dentistry full and part time over a 10-year period. Dr. Hanson is a tenured full professor of pharmacology and Vice Dean in the School of Dentistry. He was the acting director of the National Institute on Drug Abuse at the National Institutes of Health (NIH) and recognized as a leading expert on the neurobiology of the psychostimulants. Dr. Hanson has given several hundred presentations around the world on his research, and program development related to drug abuse and the Public Health implications. He also has testified multiple times before the United States Congress and the State of Utah Legislature on issues of drug abuse policy and Medicaid dental strategies and is frequently interviewed by local and international press about these topics. He is a member of the State of Utah Legislative Advisory Committee on Drugs of Abuse. He is the author of over 240 peer-reviewed scientific papers, 13 editions of a textbook entitled "Drugs and Society" and has been awarded over $35 million in NIH (National Institutes of Health) grants to conduct research related to drug abuse and its treatment. Dr. Hanson has recently been involved in studying the effects of including comprehensive dental care as part of the treatment for Substance Use Disorder Patients.